#pherv — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #pherv, aggregated by home.social.
-
👉An interesting paper :
"HERV-W ENV antigenemia and correlation of increased anti-SARS-CoV-2 immunoglobulin levels with post-COVID-19 symptoms."
" (...) The present study shows, for the first time, that the HERV-W ENV protein can still be actively expressed long after SARS-CoV-2 infection is resolved in post-COVID-19 condition patients.(...)"
There's a P2 clinical trial enrolling:
https://clinicaltrials.gov/ct2/show/NCT05497089
#Post-Covid #LongCovid #SARS-CoV-2 #Retrovirus #PHERV-W env #Temelimab #ClinicalTrial
-
👉An interesting paper :
"HERV-W ENV antigenemia and correlation of increased anti-SARS-CoV-2 immunoglobulin levels with post-COVID-19 symptoms."
" (...) The present study shows, for the first time, that the HERV-W ENV protein can still be actively expressed long after SARS-CoV-2 infection is resolved in post-COVID-19 condition patients.(...)"
There's a P2 clinical trial enrolling:
https://clinicaltrials.gov/ct2/show/NCT05497089
#Post-Covid #LongCovid #SARS-CoV-2 #Retrovirus #PHERV-W env #Temelimab #ClinicalTrial
-
👉An interesting paper :
"HERV-W ENV antigenemia and correlation of increased anti-SARS-CoV-2 immunoglobulin levels with post-COVID-19 symptoms."
" (...) The present study shows, for the first time, that the HERV-W ENV protein can still be actively expressed long after SARS-CoV-2 infection is resolved in post-COVID-19 condition patients.(...)"
There's a P2 clinical trial enrolling:
https://clinicaltrials.gov/ct2/show/NCT05497089
#Post-Covid #LongCovid #SARS-CoV-2 #Retrovirus #PHERV-W env #Temelimab #ClinicalTrial
-
👉An interesting paper :
"HERV-W ENV antigenemia and correlation of increased anti-SARS-CoV-2 immunoglobulin levels with post-COVID-19 symptoms."
" (...) The present study shows, for the first time, that the HERV-W ENV protein can still be actively expressed long after SARS-CoV-2 infection is resolved in post-COVID-19 condition patients.(...)"
There's a P2 clinical trial enrolling:
https://clinicaltrials.gov/ct2/show/NCT05497089
#Post-Covid #LongCovid #SARS-CoV-2 #Retrovirus #PHERV-W env #Temelimab #ClinicalTrial
-
👉An interesting paper :
"HERV-W ENV antigenemia and correlation of increased anti-SARS-CoV-2 immunoglobulin levels with post-COVID-19 symptoms."
" (...) The present study shows, for the first time, that the HERV-W ENV protein can still be actively expressed long after SARS-CoV-2 infection is resolved in post-COVID-19 condition patients.(...)"
There's a P2 clinical trial enrolling:
https://clinicaltrials.gov/ct2/show/NCT05497089
#Post-Covid #LongCovid #SARS-CoV-2 #Retrovirus #PHERV-W env #Temelimab #ClinicalTrial
-
Bonjour,
Pour le #CovidLong on parle dans cette courte vidéo de l'essai clinique de #phase2 en cours ciblant la #pHERV-w enveloppe chez certains malades ayant eu la #COVID19
🔗🔽
En 🇫🇷
https://youtu.be/ulIOVKTfjMEEn 🇬🇧 https://youtu.be/OwbC5e0c_7k
En 🇪🇸
https://youtu.be/03WYfkwC-zs#Après-J20
🔗 Lien vers l'étude/ The study
https://twitter.com/iguessous/status/1591705247474454528?t=t9eCU0RA_N27iYjRbh53nw&s=19🔗email : [email protected]
VOIR aussi l'annonce du recrutement des premiers patients dans l'essai (16 octobre 2022)
RT 🐦:https://twitter.com/TinaMey90814508/status/1592777012099239936?t=7wZVuw8UoyoeyK96zftSIA&s=19
-
Bonjour,
Pour le #CovidLong on parle dans cette courte vidéo de l'essai clinique de #phase2 en cours ciblant la #pHERV-w enveloppe chez certains malades ayant eu la #COVID19
🔗🔽
En 🇫🇷
https://youtu.be/ulIOVKTfjMEEn 🇬🇧 https://youtu.be/OwbC5e0c_7k
En 🇪🇸
https://youtu.be/03WYfkwC-zs#Après-J20
🔗 Lien vers l'étude/ The study
https://twitter.com/iguessous/status/1591705247474454528?t=t9eCU0RA_N27iYjRbh53nw&s=19🔗email : [email protected]